Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 5, Issue 3 (9-2016)
J Emerg Health Care 2016, 5(3): 117-120 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
almashagbeh S, Jmean A, Khasawneh H, Alsharari D, aljammal D. Mycosis Fungoides Skin Wound Management With Skin Graft Post Ultraviolet Radiation therapy. J Emerg Health Care 2016; 5 (3) :117-120
URL: http://intjmi.com/article-1-246-en.html
URL: http://intjmi.com/article-1-246-en.html
department of Dermatology, department at king Hussein Medical Center. Amman –Jordan
Abstract: (8211 Views)
Objective : To assess the survival rate of skin graft management in skin lesions of mycosis fungoides patients after therapy with ultraviolet radiation. Methods : Between February. 2011 and June 2015, 89 [8- 81 yrs. ] mycosis fungoides patients were followed up at dermatology clinic, the initial investigations were skin biopsy and the most common used therapy is photo therapy with ultraviolet radiation ( according to stage in the histopathologic reports ) Results : Of the 89 patients that we followed , 90% treated with phototherapy (80 patients ), 35% of them ( 28patients ) of these patients were managed by skin grafts of skin lesions and ulcers , 10% of them ( 3patients ) the skin graft didn’t survive without previous therapy with ultraviolet radiation , 90% (25patients ) of them the grafted areas survived after phototherapy of UVA ,UVB radiation to the potential donor site, the other 65% (52patients ) of the followed pts were managed without skin graft for the ulcerated skin lesions , 38% of them healed spontaneously , others didn’t healed for a long time and need skin graft. Conclusion: Mycosis fungoides is the most common type of cutaneous T lymphoma, pts who received phototherapy to the potential donor site has proven beneficial for skin graft survival , since ultraviolet radiation A,B ,decrease the cytotoxic T lymphocyte activity and decrease inflammatory cells in both graft and donor tissues , with decrease in the antigen presenting cells expression, which leads to decrease in the delayed type hyper sensitivity reaction and increase graft uptake.
References
1. 1. Hwang ST, Janik JE, Jaffe ES, et al; Mycosis fungoides and Sezary syndrome. Lancet. 2008 Mar 15;371(9616):945-57.
2.Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973–2002. Arch Dermatol 2007;143: 854–859 .
3.van Doorn R, van Haselen CW, van Voorst Vader PC, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000;136:504-510 .
4.Morales-Suarez-Varela MM, Olsen J, Johansen P, et al; Occupational risk factors for mycosis fungoides: a European multicenter case-control study. J Occup Environ Med. 2004 Mar;46(3):205-11.
5.Weberschock T, Strametz R, Lorenz M, et al; Interventions for mycosis fungoides. Cochrane Database Syst Rev. 2012 Sep 12;9:CD008946. doi: 10.1002/14651858.CD008946.pub2.
6. Chiaron-Sileni V, Bononi A, Veller Fornasa C, et al. Phase II trial of interferon-a-2a plus psoralen with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer 2002; 95:569-575 .
7. Whittaker SJ, Foss FM .Efficacy and tolerability of currently available therapies for the mycosis fungoides and sezary syndrome variants of cutaneous T-cell lymphoma. Cancer Treat Rev . 2007;33(2):146-160.
8. Fink-Puches R, Zenahlik P, Bäck B, et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002;99: 800-805 . 9. Horwitz SM; Novel therapies for cutaneous T-cell lymphomas. Clin Lymphoma Myeloma. 2008 Dec;8 Suppl 5:S187-92
10. Scherer-Pietramaggiori SS, Pietramaggiori G, OrgillDP.Skin graft.In:Neligan PC,ed.Plastic surgery.3rd ed.Pheladelphia, PA : Elsevier;2013:Chap 17.
11. Smith BD, Wilson LD. Management of mycosis fungoides. Oncology. 2003;17:1281–8.
12. ^Barret-Nerin, Juan; Herndon, David N . (2004) . Principles and practice of Burn surgery.New York : Marcel Dekker.
13. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K. The role of lymphocytes in human dermal wound healing. Br J Dermatol. 2000;143:59–65 .
14. Obochi MO, Ratkay LG, Levy JG. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. Transplantation. 1997;63:810–7 .
15. Tamaki K, Iijima M. The effect of ultraviolet B irradiation on delayed type hypersensitivity, cytotoxic T lymphocyte activity, and skin graft rejection. Transplantation. 1989;47:372–6 .
16. ^Jones, JE; Nelson, EA; Al-Hity, A ( Jan 31 , 2013 ). " Skin grafting for venous leg ulcers." . The Cochrane database of systematic reviews.
17 . ^emedicine > Skin Grafts, Author: Bengamin C Wood. Coauthor(s) :Christian N Kerman.updated Jan.29,2010.
18 . ^"Skin Grafting : Aftercare" . Encyclopedia of surgery. Retrieved sep 19 , 2012.
19 . Dipietro , Lusia A. , and Aime L . Burns, eds.Wound Healing: Methods and protocols. Totowa , NJ : Humana Press, 2003.
20. MERMELSTEIN FH, ABIDI TF , LASKIN JD , Mol pharmacol , 36 (1989)848.
21. Wolf, P., D. X. Nghiem, J. P. Walterscheid, S. Byrne, Y. Matsumura, Y. Matsumura, C. Bucana, H. N. Ananthaswamy, and S. E. Ullrich. 2006. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. Am. J. Pathol. 169: 795–805
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |